Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression (Q43858400)
Jump to navigation
Jump to search
scientific article published on 2 January 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression |
scientific article published on 2 January 2002 |
Statements
1 reference
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression (English)
1 reference
Eugenia Negredo
1 reference
Bonaventura Clotet
1 reference
Roger Paredes
1 reference
Guillem Sirera
1 reference
Carmina R Fumaz
1 reference
Albert Tuldrà
1 reference
Joan Romeu
1 reference
Cristina Tural
1 reference
Antoni Jou
1 reference
Anna Bonjoch
1 reference
Luís Cruz
1 reference
Lidia Ruiz
1 reference
Silvia Gel
1 reference
Montserrat Balagué
1 reference
Susan Johnston
1 reference
Albert Arnó
1 reference
2 January 2002
1 reference
1 reference
Identifiers
1 reference